Joint (JYNT) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Joint (NASDAQ:JYNT) is expected to report quarterly earnings for Q2 2025 on August 7th, forecasting earnings of ($0.07) per share and revenue of $13.32 million.
• The company has initiated a $5.00 million stock buyback program, suggesting leadership views its shares as undervalued.
• Lake Street Capital has reduced Joint's target price from $20.00 to $16.00, while maintaining a "buy" rating on the stock.

Joint (NASDAQ:JYNT - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $13.32 million for the quarter.

Joint (NASDAQ:JYNT - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). The company had revenue of $13.08 million during the quarter, compared to analyst estimates of $13.02 million. Joint had a positive return on equity of 1.60% and a negative net margin of 9.86%. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Stock Performance

NASDAQ JYNT traded down $0.11 on Friday, reaching $10.93. The company had a trading volume of 96,419 shares, compared to its average volume of 40,716. The company's fifty day moving average is $11.39 and its 200-day moving average is $11.11. Joint has a 1-year low of $9.58 and a 1-year high of $13.47. The firm has a market capitalization of $167.23 million, a price-to-earnings ratio of -18.84 and a beta of 1.53.

Joint announced that its Board of Directors has initiated a stock buyback plan on Thursday, June 5th that permits the company to repurchase $5.00 million in shares. This repurchase authorization permits the company to purchase up to 2.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its stock is undervalued.

Analysts Set New Price Targets

Separately, Lake Street Capital lowered their price target on shares of Joint from $20.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, May 9th.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.